A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer-Reference-Cited by-同舟云学术

A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer

Published:2008-01-17 Issue:3 Volume:25 Page:303-308
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Karapanagiotou Eleni M.,Charpidou Adrianni,Tzannou Ifigenia,Dilana Kalliopi,Kotteas Elias,Tourkantonis Ioannis,Kosmas Epaminondas,Provata Aspasia,Syrigos Kostas

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-007-9036-9.pdf

Reference30 articles.

1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ 1995;311(7010):899–909.

2. Johnson DH. Locally advanced, unresectable non-small cell lung cancer: new treatment strategies. Chest 2000;117(4 Suppl 1):123S–6S.

3. Socinski MA, Morris DE, Masters GA, Lilenbaum R. Chemotherapeutic management of stage IV non-small cell lung cancer. Chest 2003;123(1 Suppl):226S–43S.

4. Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002;346(2):92–8.

5. Stewart DJ, Raaphorst GP, Yau J, Beaubien AR. Active vs. passive resistance, dose-response relationships, high dose chemotherapy, and resistance modulation: a hypothesis. Invest New Drugs 1996;14(2):115–30.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II Study of Gemcitabine Plus Docetaxel as Second-Line Treatment in Malignant Pleural Mesothelioma;American Journal of Clinical Oncology;2011-02

2. Hypersensitivity Reactions to Docetaxel: Retrospective Evaluation and Development of a Desensitization Protocol;International Archives of Allergy and Immunology;2011

3. Hypersensitivity Reactions Associated with Platinum Antineoplastic Agents: A Systematic Review;Metal-Based Drugs;2010-09-20